Companies: 10,795·Total market cap: $144.5T
GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc.

GEHCNASDAQHealthcare● Active
$64.67
+$0.86(+1.35%)
Market Cap$29.4B
P/E Ratio
52W High$89.77
52W Low$58.75

GE HealthCare Technologies Inc. (GEHC) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

gehc · stock forecast · 18 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 18 Wall Street analysts in the past 3 months

SellBuy

Buy

18 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
10
Hold
8
Sell
0
Strong Sell
0
Total: 18 · Buy rate: 55.6%

12-Month Price Target

High

$105

Consensus

$83.27

+28.8% upside

Low

$65.00

Median: $85 · Last Close: $64.67

The GE HealthCare Technologies Inc. (GEHC) analyst consensus is Buy, based on ratings from 18 Wall Street analysts over the past 3 months. The average 12-month GEHC price target is $83.27, representing +28.8% upside from the current price of $64.67.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $83 (28.8%)

Consensus Target

$83.27

28.8% upside

High Target

$105

62.4%

Low Target

$65

0.5%

Current Price

$64.67

as of today

Based on analyst price targets, the GEHC stock price prediction for the next 12 months ranges from $65 to $105. The consensus GEHC price forecast of $83.27 implies 28.8% upside from the current price of $64.67.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$64.640.05%

1-day model range: $64.28–$64.99. Peak: $64.99 (-0.05%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$65+1.2%
2028$66+2.0%
2029$66+2.5%
2030$67+2.9%
2031+3.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

43%0%57%
6Buy
0Neutral
8Sell
RSI (14)71.0Overbought
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · GEHC · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$63.04BUY
MA 10$63.27BUY
MA 20$62.86BUY
MA 50$66.64SELL
MA 100$72.59SELL
MA 200$75.09SELL
Current $GEHC · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$63.49BUY
EMA 10$63.23BUY
EMA 20$63.51BUY
EMA 50$66.43SELL
EMA 100$70.19SELL
EMA 200$73.30SELL
Current $GEHC · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
UBS2026-05-21
Upgrade ↑
SellNeutral
Citigroup2026-04-30
Maintains
NeutralNeutral
Goldman Sachs2026-04-30
Downgrade ↓
BuyNeutral
Barclays2026-04-30
Maintains
Equal WeightEqual Weight
Evercore ISI Group2026-04-30
Maintains
OutperformOutperform
Wells Fargo2026-04-30
Maintains
OverweightOverweight
JP Morgan2026-04-30
Maintains
NeutralNeutral
BTIG2026-04-29
Maintains
BuyBuy
BTIG2026-04-21
Maintains
BuyBuy
Piper Sandler2026-04-17
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on GE HealthCare Technologies Inc. (GEHC) stock. Of the recent 76 rating actions, 6 were upgrades and 5 were downgrades. 18 analysts currently cover GEHC.

Analyst Recommendation Trends

Buy ratings101
Hold ratings11
Sell ratings00

GEHC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$20.5B

↓ 10.0% YoY

Revenue Next Year

$21.8B

↑ 6.2% YoY

EPS This Year

$4.55

EPS Next Year

$4.88

↑ 7.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast GEHC EPS of $4.55 for the current fiscal year, based on estimates from 14 analysts. The GEHC revenue forecast is $20.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The GEHC stock forecast is supported by two independent data sources: analyst consensus ratings from 18 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus GEHC price target is $83.27 (+28.8% upside), with an analyst consensus of Buy.

The GEHC short-term stock prediction for tomorrow is $64.64 (-0.05%). The GEHC stock price prediction for 2027 estimates an average of $65. The GEHC stock prediction for 2030 projects a range of $63–$71.

GE HealthCare Technologies Inc. trades on NASDAQ under the ticker GEHC. The GEHC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 56% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

GEHC forecast · 8 questions

According to 18 Wall Street analysts, the average 12-month GEHC price target is $83.27, with a high forecast of $105.00 and a low of $65.00. The median price target is shown in the chart above when available. This implies +28.8% potential upside from the current price of $64.67.

GEHC price targetWhat is GEHC price targetGEHC analyst price targetGEHC 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.